Brendel Financial Advisors »

Silverback Therapeutics shares owned by Brendel Financial Advisors

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Brendel Financial Advisors from 13F filings

Historical chart of Brendel Financial Advisors investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Brendel Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Brendel Financial Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $100k 18k 5.47
2023-09-30 $72k 19k 3.76